Lexaria Bioscience Corp. (LEXX)
NASDAQ: LEXX · Real-Time Price · USD
4.440
+0.260 (6.22%)
Nov 13, 2026, 4:00 PM EST - Market closed
Lexaria Bioscience Employees
Lexaria Bioscience had 7 employees as of August 31, 2025. The number of employees did not change compared to the previous year. That makes Lexaria Bioscience the 41,201st largest employer in the world and 6,266th in the United States.
Employees
7
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$27,714
Profits / Employee
-$1,104,575
Market Cap
9.35M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Aug 31, 2025 | 7 | 0 | - |
| Aug 31, 2024 | 7 | 2 | 40.00% |
| Aug 31, 2023 | 5 | -2 | -28.57% |
| Aug 31, 2022 | 7 | 1 | 16.67% |
| Aug 31, 2021 | 6 | 2 | 50.00% |
| Aug 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| CytoMed Therapeutics | 42 |
| BioLineRx | 24 |
| IN8bio | 20 |
| CalciMedica | 15 |
| Purple Biotech | 10 |
| Ensysce Biosciences | 10 |
| MetaVia | 8 |
| Immuron | 8 |
LEXX News
- 11 days ago - Lexaria Bioscience enters new pharmaceutical agreement for DehydraTECH - TheFly
- 11 days ago - Lexaria Enters a New Pharmaceutical Agreement for DehydraTECH - TheNewswire
- 18 days ago - Lexaria Bioscience announces 70th patent award - TheFly
- 18 days ago - Lexaria Celebrates its 70th Patent Award - TheNewswire
- 25 days ago - Lexaria Bioscience reaches full enrollment in GLP-1-H26-7 study - TheFly
- 25 days ago - Lexaria's Human Study GLP-1-H26-7 Reaches Full Enrollment and Continues Dosing on Schedule - TheNewswire
- 4 weeks ago - Lexaria Bioscience announces results from animal study GLP-1-A26-1 - TheFly
- 4 weeks ago - Lexaria Announces Results from Animal Study GLP-1-A26-1 - Accesswire